Tuesday, 23 Apr 2019

You are here

Epigenetic Link in Rheumatoid Arthritis to Huntington's Disease

Researchers at University of California San Diego School and the Icahn School of Medicine have found a high-resolution epigenomic landscape of rheumatoid arthritis (RA) that overlaps with that seen in Huntington's disease, suggesting potentially new unanticipated pathways that could be developed into therapeutic targets.

Their study, published in Nature Communications, presented a comprehensive epigenomic characterization of RA fibroblast-like synoviocytes and their epigenetic changes and found that epigenomically similar regions exist in RA cells that are associated with active enhancers and promoters and specific transcription factor binding motifs. Surprisingly these were similar to that seen in Huntington’s Disease, a fatal and incurable genetic brain disease. 

The investigators studied the epigenome using cells from RA joints to identifiy unique epigenetic changes. Analysis of chromatin, DNA methylation, RNA expression and histone modifications resulted in large amounts of data that were algorithmically managed to reduced the number of epigenetic combinations in the genes of patients with RA. The purpose of which was to new cell signaling pathways utilized in RA.

Epigenetics is the study of alterations in gene structure without necessarily changing the DNA sequence itself. Epigenetics have become increasingly important in understanding many disorders, as epigenetic changes can be influenced by a variety of environmental factors, including aging, activity and lifestyle choices.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Statins in RA Patients Without CVD: Nonsignificant Results

Patients with RA, but without CV disease, who were treated with atorvastatin appeared to experience cardiovascular (CV) benefits similar to what has been observed in other populations, with a risk reduction of approximately one-third, according to a large, but prematurely terminated, trial in the U.K.

Increasing Prevalence and Consequences of Interstitial Lung Disease in RA

Interstitial lung disease (ILD) has been a hot topic in numerous journals recently with reports of increasing incidence and links to disease activity.

RheumNowLive On Demand: MTX Impact in RA - Dr. Michael Weinblatt

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

RheumNowLive On Demand: Pre-Clinical RA - Dr. Michael Holers

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

Artificial Intelligence to Predict Rheumatoid Disease Activity

A recent study in JAMA Network Open shows that artificial intelligence models can use electronic health record data to prognosticate future patient outcomes in rheumatoid arthritis (RA).